Based on the results of population and clinical studies, they recommend considering the threshold values of biomarkers for HF as the cut-off points for DCM: BNP—50 pg/mL, NT-proBNP—125 pg/mL, high-sensitivity cardiac troponin—>99th percentile [2]. This evidence concerns the gene NPPB and hydrops fetalis.